Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Clinical Products Funding

3 strengths of pregabalin among second list of March price concessions

  • News

The Department of Health and Social Care and the National Assembly for Wales have agreed on concessionary prices for the following nine items for March 2021 prescriptions.

An initial 23 items were announced on March 19.

Drug
Strength
Form
Price
Duloxetine
20mg
gastro-resistant capsules (28)
£7.75
Eplerenone
50mg
tablets (28)
£25.49
Irbesartan/ Hydrochlorothiazide
300mg/12.5g
tablets (28)
£15.93
Pregabalin
200mg
capsules (84)
£7.79
Pregabalin
50mg
capsules (84)
£5.11
Pregabalin
75mg
capsules (56)
£5.32
Ropinirole
1mg
tablets (84)
£25.99
Trimethoprim
50mg/5ml
sugar-free oral suspension (100ml)
£9.99
Zonisamide
100mg
capsules (56)
£54.80
Table

View full table

Do these prices reflect the ones you have paid so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Clinical Products Funding
Latest News & Analysis

Covert surveillance: GPhC may abandon ‘never used’ spying powers

Extra £9m cash injection for growing Glasgow digital pharmacy Phlo

Revealed: 97% spike in number of pharmacists seeking debt support

GPhC to 'assess' pharmacy technician minimum training levels

See All
UsernamePublicRestriction

Register

CD007092

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By